Simmunome AI

Simmunome AI

Signal active

Organization

Contact Information

Overview

Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy

About

Industries

Biotechnology, Artificial Intelligence (AI), Health Care, Genetics

Founded

2016

Employees

1-10

Headquarters locations

Montreal, Quebec, Canada, North America

Social

Profile Resume

Simmunome AI headquartered in North America, operates in the Biotechnology, Artificial Intelligence (AI), Health Care, Genetics sector. The company focuses on Biotechnology and has secured $71.2M in funding across 48 round(s). With a team of 1-10 employees, Simmunome AI is actively contributing to advancements in Biotechnology. Their latest funding round, Pre Seed Round - Simmunome AI, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Nardin Nakhla

Nardin Nakhla

CTO and Co-Founder

Funding Rounds

Funding rounds

3

Investors

1

Lead Investors

0

Total Funding Amount

$1.5M

Details

3

Simmunome AI has raised a total of $1.5M in funding over 3 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2020Seed
2023Seed1.5M
2024Seed

Investors

Simmunome AI is funded by 14 investors.

Investor NameLead InvestorFunding RoundPartners
Benoit M Leroux-FUNDING ROUND - Benoit M Leroux1.5M
Simmunome AI-FUNDING ROUND - Simmunome AI1.5M
The Fonds d’investissement Eurêka-FUNDING ROUND - The Fonds d’investissement Eurêka1.5M
Simmunome AI-FUNDING ROUND - Simmunome AIundefined